Out-licensing
Up-to-date access to technology licensing opportunities worldwide.
- Out-licensing
- Browse
Licensing opportunities
Reperfusions can lead to severe damage in patients with heart attacks and strokes, the SOD-nanoparticles would be highly beneficial for use in hospitals for treating these patients. More
A novel series of NMDA receptor antagonists, which shows different selectivity for NMDA receptors than the previously described NMDA receptor antagonists. More
Method and Composition for Optimizing Left Ventricular Videointensity in Echocardiography (TID - 73)
Composition for Optimizing Left Ventricular Videointensity More
Cancer immunotherapy using dendritic cells, and iii) Camel recombinant antibodies for FoxP3, Mucl & CEA. More
Genetic cloning and sequencing of a novel IL-17 receptor-related gene More
Heart failure is associated with cardiac hypertropy, atheiosclerosis, myocardial infarction, valvular heart disease and hypertension. Many researches has focused on development of cardiotonics for treating heart failure. More
A vector to be used for transfection and purification of human soluble FcRn receptor More
Novel methods of cell culture for production of human parvovirus B19 (B19). These specific cell lines demonstrate limited infectability and commonly produce little or no virus following initial inoculation with B19. More
Metabolomic assessment of the different Cytochrome P450 and UDP-Glucuronosyltransferase contributions to Warfarin Metabolism in individual patients More
Development of Lodamin: A Novel Oral Anti-Angiogenic Polymeric Drug More
Related Reports
Market Research Reports provided by reports.iptechex.com
Mar 2011 - 6 pages - $500
Nov 2010 - 40 pages - $500
May 2011 - 15 pages - $125
Mar 2008 - 250 pages - $3,995
May 2011 - 396 pages - $2,265
May 2011 - 23 pages - $125
May 2011 - 15 pages - $250
May 2011 - 15 pages - $250
Sep 2010 - 25 pages - $125
Sep 2010 - 25 pages - $125
Your selection
- Therapeutic target
- Blood and forming organs del
Browse By
- Industry sector
- Animal health
- Biotechnology
- Diagnostic
- Drug delivery
- Drug discovery
- Medical device
- Pharmaceutical
- Research tools
- Therapeutic target
- Blood composition
- Blood disorders
- Blood substitute
- Blood Transfusion
- Fibrogenesis
- Hemorrhagic trauma
- Lymphatic disorders
- Sepsis
- Thrombosis
- Whole blood substitute
- Development phase
- Early Stage
- Preclinical
- Phase I
- Phase I/II
- Phase II
- Phase III
- Phase III/IV
- Preregistration
- Registered
© Copyright 1998-2013 IP Technology Exchange, Inc All rights reserved. Terms and Conditions | Contact us